5

FORM 5 SUBMISSION

Company: ARROWHEAD PHARMACEUTICALS, INC.
Filed: September 30, 2022
Period of Report: September 30, 2022
Accession Number: 0001209191-22-051673

View Document ↗ View on SEC.gov ↗